<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>HIV Archives - Iran News Daily</title>
	<atom:link href="https://irannewsdaily.com/tag/hiv/feed/" rel="self" type="application/rss+xml" />
	<link>https://irannewsdaily.com/tag/hiv/</link>
	<description></description>
	<lastBuildDate>Mon, 28 Nov 2022 21:54:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.4</generator>

<image>
	<url>https://irannewsdaily.com/wp-content/uploads/2020/04/cropped-iranlogo-32x32.png</url>
	<title>HIV Archives - Iran News Daily</title>
	<link>https://irannewsdaily.com/tag/hiv/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>HIV no longer fatal</title>
		<link>https://irannewsdaily.com/2022/11/hiv-no-longer-fatal/</link>
					<comments>https://irannewsdaily.com/2022/11/hiv-no-longer-fatal/#respond</comments>
		
		<dc:creator><![CDATA[mahla]]></dc:creator>
		<pubDate>Mon, 28 Nov 2022 21:54:44 +0000</pubDate>
				<category><![CDATA[important news]]></category>
		<category><![CDATA[Society]]></category>
		<category><![CDATA[HIV]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=141215</guid>

					<description><![CDATA[<p>TEHRAN (Iran News) –HIV is no longer deadly since years ago, and if diagnosed and treated in time, it will not turn into AIDS and can be kept under control. Untreated, HIV typically turns into AIDS in about 8 to 10 years. When AIDS occurs, the immune system has been severely damaged. The patient will [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2022/11/hiv-no-longer-fatal/">HIV no longer fatal</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary">TEHRAN (<a href="https://www.irannewsdaily.com/">Iran News</a>) –HIV is no longer deadly since years ago, and if diagnosed and treated in time, it will not turn into AIDS and can be kept under control.</p>
<p>Untreated, HIV typically turns into AIDS in about 8 to 10 years. When AIDS occurs, the immune system has been severely damaged. The patient will more likely to develop diseases that would not usually cause illness in a person with a healthy immune system. These are called opportunistic infections or opportunistic cancers.</p>
<p>Since the outbreak of coronavirus, HIV care and treatment services were affected due to the fear of patients referring to treatment centers. This year’s slogan emphasizes the need for access to diagnostic services for all, epidemiologist Seyed Ahmad Seyed-Alinaghi told ISNA on the occasion of World AIDS Day.</p>
<p><cite class="quote-t7"><strong>A campaign called &#8220;I test for HIV, too&#8221;, started on November 11 aiming to identify HIV patients, and increase universal access to training and diagnosis.</strong></cite>World AIDS Day, designated on December 1 every year since 1988, is an international day dedicated to raising awareness of the AIDS pandemic caused by the spread of HIV infection and mourning those who have died of the disease.</p>
<p>The 2022 theme is “Putting Ourselves to the Test: Achieving Equity to End HIV”.</p>
<p>Pointing to the statistics of HIV incidence in the country, Seyed-Alinaghi stated that the estimate shows that 55,000 people are infected. But the statistics indicate 44,000 registered HIV infections, not all of them are alive and the alive patients are 23,000, and not all of them are receiving treatment.</p>
<p>But those who are under treatment are in good condition and the disease is controlled in their body. About 16,000 of them go to counseling centers, and continuously receive medical services, he explained.</p>
<p>He went on to note that about 19 percent of the 44,000 patients are women and 81 percent are men. Of course, it seems that the percentage of female patients is increasing now, despite the fact that it was single-digit in the past.</p>
<p>Currently, about 58 percent of people are infected with unsafe injecting drug use, about 24 percent through unprotected sexual relations, mother-to-child transmission constitutes 1.7 percent, and about 0.2 percent through blood products.</p>
<p>Most of the patients, accounting for over 50 percent, are aged 25 to 39 years, he said.</p>
<p>Referring to the birth of healthy children from mothers and fathers with HIV, he said that if these people adhere to the treatment and the virus is contained in their bodies, they can have healthy children.</p>
<p>Being treated for HIV, in addition to being beneficial for the patient and their quality of life, causes the number of viruses to decrease and prevents the transmission of the disease in society; he said, emphasizing the need for early diagnosing of the disease.</p>
<p>Currently, there are effective HIV treatments that can keep the disease under control by taking one or two pills a day, he added.</p>
<p><strong> HIV campaign</strong></p>
<p>A campaign was launched to test the public for HIV, through which over 100,000 tests have been carried out nationwide, ILNA reported.</p>
<p>The campaign, called &#8220;I test for HIV, too&#8221;, began on November 11 for a month, aiming to identify HIV patients in targeted populations, and increase universal access to HIV training and diagnosis.</p>
<p>The results showed that in total from the beginning of the campaign, 100,221 diagnostic tests were carried out in 1,411 centers, and from 310 primary positive cases, 114 cases have been referred to counseling centers for confirmation.</p>
<p><strong> Prevalence in the world</strong></p>
<p>The human immunodeficiency viruses are two species of Lentivirus that cause HIV infection and over time acquired immunodeficiency syndrome. AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive.</p>
<p>Since the beginning of the epidemic, 75 million people have been infected with the HIV virus and about 32 million people have died of HIV.</p>
<p>Globally, 37.9 million people were living with HIV at the end of 2018. An estimated 0.8% [0.6-0.9%] of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions.</p>
<p>The WHO African region remains most severely affected, with nearly 1 in every 25 adults (3.9%) living with HIV and accounting for more than two-thirds of the people living with HIV worldwide.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2022/11/hiv-no-longer-fatal/">HIV no longer fatal</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2022/11/hiv-no-longer-fatal/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Clinical trial on effectiveness of favipiravir starts</title>
		<link>https://irannewsdaily.com/2020/04/clinical-trial-on-effectiveness-of-favipiravir-starts/</link>
					<comments>https://irannewsdaily.com/2020/04/clinical-trial-on-effectiveness-of-favipiravir-starts/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Tue, 07 Apr 2020 10:14:24 +0000</pubDate>
				<category><![CDATA[domestic]]></category>
		<category><![CDATA[Science]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Favipiravir]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[HIV]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=108208</guid>

					<description><![CDATA[<p>TEHRAN (Iran News) – Iranian medical authorities have agreed on carrying out a clinical trial on the effectiveness of favipiravir, a drug originally used in Japan for the treatment of new types of influenza. Shahid Beheshti University of Medical Sciences has announced that a clinical trial began by Tehran’s Masih Daneshvari hospital on Sunday aimed [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2020/04/clinical-trial-on-effectiveness-of-favipiravir-starts/">Clinical trial on effectiveness of favipiravir starts</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>TEHRAN (<a href="https://irannewsdaily.com/" target="_blank" rel="noopener noreferrer">Iran News</a>) – Iranian medical authorities have agreed on carrying out a clinical trial on the effectiveness of favipiravir, a drug originally used in Japan for the treatment of new types of influenza.</p>
<div class="item-body">
<div class="item-text">
<p>Shahid Beheshti University of Medical Sciences has announced that a clinical trial began by Tehran’s Masih Daneshvari hospital on Sunday aimed at determining favipiravir’s effectiveness in treating patients infected with COVID-19.</p>
<p>Favipiravir, also known as Avigan, was developed by Fujifilm Toyama Chemical in 2014 used for the treatment of new strains of influenza.</p>
<p>The announcement underlines that efforts for drug synthesis as well as the pharmaceutical formulation of favipiravir have been invested in Iran since early March and the drug will be domestically produced in the country should the trial demonstrate its effectiveness in relieving symptoms caused by a coronavirus.</p>
<p>Zhang Xinmin, director of China&#8217;s National Center for Biotechnology Development, said on March 17 that favipiravir had shown encouraging outcomes in clinical trials in Wuhan and Shenzhen involving 340 patients.</p>
<p>He said those who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, while it took a median of 11 days for those without the drug, NHK reported.</p>
<p>“The trial also found that X-ray photos confirmed improvements in lung conditions in about 91 percent of the patients who were given the medicine. The number stood at 62 percent for those without the drug.”</p>
<p>“It has a high degree of safety and is effective in treatment,” Zhang highlighted.</p>
<p>According to the Mainichi, Japan’s National Daily, Clinical research using favipiravir on novel coronavirus disease patients with mild to moderate symptoms began in March in the country, in the hope that the medication will be effective in preventing the virus from multiplying in patients’ body.</p>
<p>Nevertheless, an individual related to Japan&#8217;s Ministry of Health Labor and Welfare has said that &#8220;We&#8217;ve given Avigan to 70 to 80 people, but it doesn&#8217;t seem to work that well when the virus has already multiplied.&#8221;</p>
<p>Moreover, care is said to be needed when women who could be pregnant or men who are trying to have children, as it can subsequently cause deformities in fetuses.</p>
<p><strong>Solidarity trial</strong></p>
<p>Since the pandemic has started to take a toll on almost all countries worldwide World Health Organization has set up an international trial, also known as solidarity trial, which is comparing four treatment options to assess their effectiveness against COVID-19. Involving all countries affected by the virus in one trial instead of multiple small trials will generate strong evidence needed to determine the effectiveness of potential treatment.</p>
<p>Furthermore, according to WHO, while randomized clinical trials normally take years to design and complete, the solidarity trial will reduce the time taken by 80 percent.</p>
<p>As of March 27, over 70 countries have already confirmed they will contribute to the trial, with many others in the process of joining.</p>
<p>Based on evidence from laboratory, animal and clinical studies, the following treatment options were selected: Remdesivir; Lopinavir/Ritonavir; Lopinavir/Ritonavir with Interferon beta-1a; and Chloroquine or Hydroxychloroquine.</p>
<p>Remdesivir was previously tested as an Ebola treatment. It has generated promising results in animal studies for Middle East Respiratory Syndrome (MERS-CoV) and severe acute respiratory syndrome (SARS), which are also caused by coronaviruses, suggesting it may have some effect in patients with COVID-19.</p>
<p>Lopinavir/Ritonavir is a licensed treatment for HIV. Evidence for COVID-19, MERS, and SARS is yet to show it can improve clinical outcomes or prevent infection. This trial aims to identify and confirm any benefit for COVID-19 patients. While there are indications from laboratory experiments that this combination may be effective against COVID-19, studies done so far in COVID-19 patients have been inconclusive.</p>
<p>Interferon-beta-1a is used to treat multiple sclerosis.</p>
<p>Chloroquine and hydroxychloroquine are very closely related and used to treat malaria and rheumatology conditions respectively. In China and France, small studies provided some indications of possible benefits of chloroquine phosphate against pneumonia caused by COVID-19 but need confirmation through randomized trials.</p>
<p><strong>APN01, a would-be promising drug for COVID-19</strong></p>
<p>WHO has stated on numerous occasions that there are no medications for the treatment of COVID-19 and all drugs used for the treatment of the patients are still under trial.</p>
<p>So far, all the drugs used for reducing symptoms associated with the virus were originally prescribed for other conditions such as HIV or malaria, but they have shown some positive effects on the treatment of COVID-19 as well by either shortening the duration of the virus or preventing it from replication at early stages.</p>
<p>However, according to the trial site news, the University of British Columbia investigator-led an international team that has discovered an experimental drug that effectively blocks the cellular door to SARS-CoV-2 used to infect its hosts.</p>
<p>This multinational research effort concludes that an investigational treatment called APN01 (recombinant human angiotensin-converting enzyme 2 or rhACE2) may be capable of inhibiting COVID-19 by reducing the SARS-CoV-2 load that penetrates the lungs and other organs. A Vienna Austria-based biotech named Aperion Biologics will now take APN01 into clinical trials in Europe.</p>
<p>Worldwide, there are over 1.1 million confirmed cases of coronavirus and nearly 63,000 deaths are reported. The pandemic has affected 209 countries, areas or territories.</p>
<p>While the world is hoping and striving for the best treatment option as well as a vaccine to minimize or stop deaths as well as decreasing economic consequences brought about by the luck downs we all still have to stay at home as much as possible, practice hand hygiene and cough etiquette to both protect ourselves as well as others, especially vulnerable individuals, to limit the virus transmission and reduce the pressure on the health system.</p>
</div>
</div>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2020/04/clinical-trial-on-effectiveness-of-favipiravir-starts/">Clinical trial on effectiveness of favipiravir starts</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2020/04/clinical-trial-on-effectiveness-of-favipiravir-starts/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>20,000 new HIV cases in Pakistan annually</title>
		<link>https://irannewsdaily.com/2018/12/20000-new-hiv-cases-in-pakistan-annually/</link>
					<comments>https://irannewsdaily.com/2018/12/20000-new-hiv-cases-in-pakistan-annually/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Tue, 04 Dec 2018 09:10:40 +0000</pubDate>
				<category><![CDATA[international]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[Pakistan]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=44129</guid>

					<description><![CDATA[<p>In an alarming development, Pakistan is registering approximately 20,000 new HIV cases annually, the highest rate among all countries in the region, according to the World Health Organization (WHO). The international body says mortality among Pakistanis living with the virus, which causes the deadly AIDS disease, is also rising, in spite of the availability of [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/12/20000-new-hiv-cases-in-pakistan-annually/">20,000 new HIV cases in Pakistan annually</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary">In an alarming development, Pakistan is registering approximately 20,000 new HIV cases annually, the highest rate among all countries in the region, according to the World Health Organization (WHO).</p>
<p>The international body says mortality among Pakistanis living with the virus, which causes the deadly AIDS disease, is also rising, in spite of the availability of lifesaving antiretroviral therapy.</p>
<p>The latest government figures show that only 16 percent of the estimated 150,000 people living with HIV had been tested and only 9 percent have access to lifesaving treatment.</p>
<p>“The remaining 135,000 people are walking around in the communities as carriers of (HIV) infection who are ready to transmit infections to those who are not infected, even to their unborn babies,” Dr. Saima Paracha of the National AIDS Control Program, was quoted saying in media.</p>
<p>Pakistani officials say the HIV epidemic in Pakistan remains largely concentrated among the key populations, including people who inject drugs, the transgender community, sex workers and their clients and men who have sex with men.</p>
<p>The fear of maltreatment, and punitive actions by law enforcers impacts the willingness of these populations to pursue testing, which remains a major challenge facing national efforts to treat and prevent the spread of HIV, Dr. Paracha lamented.</p>
<p>Official estimates show that Pakistan has seen a 45 percent increase in new HIV infections since 2010.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/12/20000-new-hiv-cases-in-pakistan-annually/">20,000 new HIV cases in Pakistan annually</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2018/12/20000-new-hiv-cases-in-pakistan-annually/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Third international AIDS conference opens in Tehran</title>
		<link>https://irannewsdaily.com/2018/11/third-international-aids-conference-opens-in-tehran/</link>
					<comments>https://irannewsdaily.com/2018/11/third-international-aids-conference-opens-in-tehran/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Sat, 24 Nov 2018 04:41:59 +0000</pubDate>
				<category><![CDATA[international]]></category>
		<category><![CDATA[AIDS]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[international AIDS conference]]></category>
		<category><![CDATA[tehran]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=43293</guid>

					<description><![CDATA[<p>Third International Conference and the 7th National AIDS Seminar is taking place in Tehran from November 21 to 23, ISNA quoted the conference’s scientific director as saying. Early diagnosis of AID/HIV patients, educational and preventive programs for controlling the disease and devoting extra attention to sexual transmission of the disease are the main topics of [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/11/third-international-aids-conference-opens-in-tehran/">Third international AIDS conference opens in Tehran</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary">Third International Conference and the 7th National AIDS Seminar is taking place in Tehran from November 21 to 23, ISNA quoted the conference’s scientific director as saying.</p>
<p>Early diagnosis of AID/HIV patients, educational and preventive programs for controlling the disease and devoting extra attention to sexual transmission of the disease are the main topics of this year’s conference, Masoud Mardani announced.<br />
It is estimated that over 66,000 people in Iran have AIDS/HIV but over one third of them don’t know they have the disease or deny it. This leads to adverse consequences for the society as they may transfer the disease to other people, he said, adding that identifying and treating these people is among the most important topics of the conference.<br />
AIDS epidemiology in Iran has changed as using infected needles for injection of drugs is still the main method of transmission of the disease, but the rate of sexual transmission of the disease is growing, affecting specially the young and teenagers, he said.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/11/third-international-aids-conference-opens-in-tehran/">Third international AIDS conference opens in Tehran</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2018/11/third-international-aids-conference-opens-in-tehran/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Harm reduction prevents spread of HIV, says official</title>
		<link>https://irannewsdaily.com/2018/08/harm-reduction-prevents-spread-of-hiv-says-official/</link>
					<comments>https://irannewsdaily.com/2018/08/harm-reduction-prevents-spread-of-hiv-says-official/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Sun, 05 Aug 2018 06:00:53 +0000</pubDate>
				<category><![CDATA[feature]]></category>
		<category><![CDATA[HIV]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=33803</guid>

					<description><![CDATA[<p>TEHRAN — Harm reduction prevents spread of HIV and will help guarantee a great deal of drug users’ health, head of harm reduction office of Iran’s Welfare Organization has said, ISNA reported on Saturday. Harm reduction refers to policies, programmes and practices that aim primarily to reduce the adverse health, social and economic consequences of [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/08/harm-reduction-prevents-spread-of-hiv-says-official/">Harm reduction prevents spread of HIV, says official</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary">TEHRAN — Harm reduction prevents spread of HIV and will help guarantee a great deal of drug users’ health, head of harm reduction office of Iran’s Welfare Organization has said, ISNA reported on Saturday.</p>
<p>Harm reduction refers to policies, programmes and practices that aim primarily to reduce the adverse health, social and economic consequences of the use of legal and illegal psychoactive drugs without necessarily reducing drug consumption. Harm reduction benefits people who use drugs, their families and the community.</p>
<p>According to Harm Reduction International (HRI), a non-governmental organization in Special Consultative Status with the United Nations Economic and Social Council, harm reduction began to be discussed frequently after the threat of HIV spreading among and from injecting drug users was first recognized.</p>
<p>Harm reduction complements approaches that seek to prevent or reduce the overall level of drug consumption. It is based on the recognition that many people throughout the world continue to use psychoactive drugs despite even the strongest efforts to prevent the initiation or continued use of drugs.</p>
<p>Therefore, harm reduction accepts that many people who use drugs are unable or unwilling to stop using drugs at any given time. Access to good treatment is important for people with drug problems, but many people with drug problems are unable or unwilling to get treatment.</p>
<p>“Harm reduction is different from treating drug addiction and prevention of drug misuse,” Kambiz Mahzari said, adding that the office mainly targets drug addict who inject drugs and help decrease the harm gradually within the framework of long-term plans.</p>
<p>Harm reduction helps reduce the damages drug use can bring about for the addicts regardless of the efforts for treatment of prevention of drug misuse, Mahzari explained.</p>
<p>He went on to say that harm reduction can gradually lead to treatment of the drug users as addicts are physically and mentally hurt and cannot stop using drugs at once.</p>
<p>But since harm reduction is easier than getting treatment they prove to be more effective, he said, stating that, many of the drug addicts would voluntarily ask for treatment after receiving harm reduction services.</p>
<p><strong>limited budget for supporting HIV/AIDS patients</strong></p>
<p>The organization has a tight budget for supporting HIV/AIDS patients, director for addiction prevention and treatment department of the organization Farid Barati-Sadeh has said.</p>
<p>It is the only entity that offers services to these patients and this is while such people should be provided with special supports, Barati-Sadeh explained.</p>
<p>The organization offers services to 15,000 patients with HIV/AIDS, but such people need special social support and should be provided with minimum services, however, the Welfare Organization’s limited budget won’t do, he regretted.</p>
<p>He went on to say that other entities such as the Budget and planning Organization, the Ministry of Health, the Ministry of Welfare and the Ministry of Interior should also support such patients.</p>
<p>Currently “positive clubs” affiliated to Welfare Organization in various provinces are offering services to people with HIV/AIDS and their family members, he added.</p>
<p>Positive clubs teach the patients techniques for living positively with HIV, creating jobs, conducting recreational activities and partially covering the patient’s medical expenses, Barati-Sadeh highlighted.</p>
<p>While now participating in risky sexual behavior are increasingly constituting HIV transmission, still addiction [and sharing needles to inject drugs] is the primary cause of HIV spread in Iran, he explained.</p>
<p><strong>HIV/AIDS prevalence in Iran </strong></p>
<p>As per the figures announced by Ministry of Health center for communicable diseases management some 37,650 are diagnosed with HIV/AIDS until the end of the previous Iranian calendar year 1396  (March 20) in Iran.</p>
<p>Some 83 percent of the patients are men and the rest are women. Almost half of the patients are ageing 21-35. Out of the 37,650 individuals diagnosed with the virus so far some 13,393 have died. The HIV have led to AIDS in 15,278 of the patients, the report stated.</p>
<p>Sharing the same needle for injection of drugs with 61.7 percent accounts for the highest number of HIV transmission in the country, while high risk sexual behavior are responsible for 21.3 percent of the infections. The report also indicated that some 1.5 percent of the infection transmission are passed from mother to her child. The rest of the cases are infected with the virus for unknown reasons.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/08/harm-reduction-prevents-spread-of-hiv-says-official/">Harm reduction prevents spread of HIV, says official</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2018/08/harm-reduction-prevents-spread-of-hiv-says-official/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Iran running HIV prevention programs for at-risk women, youth</title>
		<link>https://irannewsdaily.com/2018/05/iran-running-hiv-prevention-programs-for-at-risk-women-youth/</link>
					<comments>https://irannewsdaily.com/2018/05/iran-running-hiv-prevention-programs-for-at-risk-women-youth/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Thu, 24 May 2018 05:10:01 +0000</pubDate>
				<category><![CDATA[domestic]]></category>
		<category><![CDATA[HIV]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=28349</guid>

					<description><![CDATA[<p>TEHRAN — Iran is conducting HIV prevention programs to protect vulnerable women and at-risk youth from catching the virus, Health Minister Hassan Qazizadeh- Hashemi said on Tuesday. He made the remarks during his speech at the 71st World Health Assembly (WHA) side event titled “towards universal coverage with HIV prevention services and commodities – the [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/05/iran-running-hiv-prevention-programs-for-at-risk-women-youth/">Iran running HIV prevention programs for at-risk women, youth</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary"><strong>TEHRAN — Iran is conducting HIV prevention programs to protect vulnerable women and at-risk youth from catching the virus, Health Minister Hassan Qazizadeh- Hashemi said on Tuesday.</strong></p>
<p>He made the remarks during his speech at the 71st World Health Assembly (WHA) side event titled “towards universal coverage with HIV prevention services and commodities – the Global Prevention Coalition and Roadmap” held on May 22.</p>
<p>Delegations of Ecuador, Haiti, the Islamic Republic of Iran, Luxembourg, Maldives, Mexico, Panama, Ukraine, the United Kingdom of Great Britain and Northern Ireland and the African Group are the organizers if the event.</p>
<p>“It is globally proved that once prevention programs ceased to be implemented, epidemics strike,” the minister said, adding, “Iran not only pursue Joint United Nations Programme on HIV and AIDS (UNAIDS) goals but also carry out prevention of mother-to-child transmission (PMTCT) programmes.”</p>
<p>Moreover, special centers offering services to vulnerable women also provide them with consultation, HIV testing, tips for healthy pregnancy and social support, he noted.</p>
<p>Offering services to couples living with HIV when one partner is positive and the other is negative, is part of the HIV prevention programs in Iran as well, he highlighted.</p>
<p>The mission of UNAIDS is to lead, strengthen and support an expanded response to HIV and AIDS that includes preventing transmission of HIV, providing care and support to those already living with the virus, minimizing the vulnerability of individuals and communities to HIV and alleviating the impact of the epidemic. UNAIDS seeks to prevent the HIV/AIDS epidemic from becoming a severe pandemic.</p>
<p>UNAIDS has five goals including leadership and advocacy for effective action on the pandemic; strategic information and technical support to guide efforts against AIDS worldwide; tracking, monitoring and evaluation of the pandemic and of responses to it; civil society engagement and the development of strategic partnerships; and mobilization of resources to support an effective response.</p>
<p>The World Health Assembly is the supreme decision-making body for WHO. It generally meets in Geneva in May each year, and is attended by delegations from all 194 Member States. Its main function is to determine the policies of the Organization, appoint the Director-General, supervise financial policies, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland. The 71st World Health Assembly is underway in Geneva on May 21-26.</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2018/05/iran-running-hiv-prevention-programs-for-at-risk-women-youth/">Iran running HIV prevention programs for at-risk women, youth</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2018/05/iran-running-hiv-prevention-programs-for-at-risk-women-youth/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Over 36,000 Iranians living with HIV: Health official</title>
		<link>https://irannewsdaily.com/2017/12/36000-iranians-living-hiv-health-official/</link>
					<comments>https://irannewsdaily.com/2017/12/36000-iranians-living-hiv-health-official/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Fri, 01 Dec 2017 06:30:33 +0000</pubDate>
				<category><![CDATA[domestic]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[IRAN]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=16383</guid>

					<description><![CDATA[<p>TEHRAN — As per the latest statistics published by Iran’s Ministry of Health, 36,039 individuals were suffering from HIV in the country until late June, a health official has said. The number only accounts for 30 percent of the individuals who are affected with the virus and the ministry have reasons to believe that some [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2017/12/36000-iranians-living-hiv-health-official/">Over 36,000 Iranians living with HIV: Health official</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p class="summary"><strong>TEHRAN — As per the latest statistics published by Iran’s Ministry of Health, 36,039 individuals were suffering from HIV in the country until late June, a health official has said.</strong></p>
<p>The number only accounts for 30 percent of the individuals who are affected with the virus and the ministry have reasons to believe that some 70 percent of those who are infected by the virus are still undiagnosed, Parvin Kazerouni, head of AIDS department of the Ministry of Health, explained.</p>
<p>Of the 36,039 patients suffering the infection 84 percent are men and the rest are women, ISNA news agency quoted Kazerouni as saying. “52 percent of the HIV sufferers age between 21 to 35 years old.”</p>
<p>Some 9,764 individuals diagnosed with HIV are dead and 14,656 are at the very final stage of HIV infection, known as AIDS, she added.</p>
<p>Overall sharing contaminated needles, syringes and other injecting equipment and drug solutions when injecting drugs is still the major cause of HIV transmission in Iran.</p>
<p>However, the ministry have worries over the shifting patterns of HIV transmission in the country as having unprotected and high risk sexual intercourses are becoming the leading cause of the virus transmission.</p>
<p>For one, as Kazerouni have explained some 33 percent of the cases diagnosed with HIV over the first three months of the current year (March 21 to June 21) were women and that 47.8 percent of the cases have most probably contracted with the virus by having unprotected sexual relationships.</p>
<p>Some 32.7 are infected by sharing drug needles with someone who is infected with HIV, 2 percent of the cases are attributed to mother-to-child transmission of Aids [the spread of HIV from a woman living with HIV to her child during pregnancy, childbirth, or breastfeeding] and 17.4 have got the virus through other ways, she highlighted.</p>
<p>Iran joined “Ending the AIDS epidemic by 2030” international program to halt spread of the disease by 2030 and committed to “Target 90-90-90” which aims at HIV treatment and prevention for 2020, she said.</p>
<p>Ending the AIDS epidemic by 2030 is a fast-track strategy of the United Nations which proposes rapid and massive acceleration of HIV prevention and treatment programs for ending the AIDS epidemic by 2030. Target 90-90-90 would enable 90 percent of people living with HIV to know their HIV status, 90 percent of people who know their status to access Aids treatment and 90 percent of people on HIV treatment to achieve viral suppression.</p>
<p>According to World Health Organization (WHO) HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2016, 1.0 million people died from Aids-related causes globally.</p>
<p>There were approximately 36.7 million people living with HIV at the end of 2016 with 1.8 million people becoming newly infected in 2016 globally.</p>
<p>54% of adults and 43% of children living with HIV are currently receiving lifelong antiretroviral therapy (ART).</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2017/12/36000-iranians-living-hiv-health-official/">Over 36,000 Iranians living with HIV: Health official</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2017/12/36000-iranians-living-hiv-health-official/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>New Molecule Shows Promise in HIV Vaccine Design</title>
		<link>https://irannewsdaily.com/2017/10/molecule-promise-hiv-vaccine/</link>
					<comments>https://irannewsdaily.com/2017/10/molecule-promise-hiv-vaccine/#respond</comments>
		
		<dc:creator><![CDATA[reporter 1222]]></dc:creator>
		<pubDate>Mon, 30 Oct 2017 06:39:52 +0000</pubDate>
				<category><![CDATA[technology]]></category>
		<category><![CDATA[HIV]]></category>
		<category><![CDATA[melocule]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://irannewsdaily.com/?p=13365</guid>

					<description><![CDATA[<p>TEHRAN- Researchers have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine. Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate [&#8230;]</p>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2017/10/molecule-promise-hiv-vaccine/">New Molecule Shows Promise in HIV Vaccine Design</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h3 class="lead">TEHRAN- Researchers have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.</h3>
<div class="story">
<p>Researchers at the University of Maryland and Duke University have designed a novel protein-sugar vaccine candidate that, in an animal model, stimulated an immune response against sugars that form a protective shield around HIV. The molecule could one day become part of a successful HIV vaccine.</p>
<p>&#8220;An obstacle to creating an effective HIV vaccine is the difficulty of getting the immune system to generate antibodies against the sugar shield of multiple HIV strains,&#8221; said Lai-Xi Wang, a professor of chemistry and biochemistry at UMD. &#8220;Our method addresses this problem by designing a vaccine component that mimics a protein-sugar part of this shield.&#8221;</p>
<p>Wang and collaborators designed a vaccine candidate using an HIV protein fragment linked to a sugar group. When injected into rabbits, the vaccine candidate stimulated antibody responses against the sugar shield in four different HIV strains. The results were published in the journal Cell Chemical Biology on October 26, 2017.</p>
<p>The protein fragment of the vaccine candidate comes from gp120, a protein that covers HIV like a protective envelope. A sugar shield covers the gp120 envelope, bolstering HIV&#8217;s defenses. The rare HIV-infected individuals who can keep the virus at bay without medication typically have antibodies that attack gp120, Science Daily reported.</p>
<p>Researchers have tried to create an HIV vaccine targeting gp120, but had little success for two reasons. First, the sugar shield on HIV resembles sugars found in the human body and therefore does not stimulate a strong immune response. Second, more than 60 strains of HIV exist and the virus mutates frequently. As a result, antibodies against gp120 from one HIV strain will not protect against other strains or a mutant strain.</p>
<p>To overcome these challenges, Wang and his collaborators focused on a small fragment of gp120 protein that is common among HIV strains. The researchers used a synthetic chemistry method they previously developed to combine the gp120 fragment with a sugar molecule, also shared among HIV strains, to mimic the sugar shield on the HIV envelope.</p>
<p>Next, the researchers injected the protein-sugar vaccine candidate into rabbits and found that the rabbits&#8217; immune systems produced antibodies that physically bound to gp120 found in four dominant strains of HIV in circulation today. Injecting rabbits with a vaccine candidate that contained the protein fragment without the sugar group resulted in antibodies that primarily bound to gp120 from only one HIV strain.</p>
<p>&#8220;This result was significant because producing antibodies that directly target the defensive sugar shield is an important step in developing immunity against the target and therefore the first step in developing a truly effective vaccine,&#8221; Wang said.</p>
<p>Although the rabbits&#8217; antibodies bound to gp120, they did not prevent live HIV from infecting cells. This result did not surprise Wang, who noted that it usually takes humans up to two years to build immunity against HIV and the animal study only lasted two months.</p>
<p>&#8220;We have not hit a home run yet,&#8221; Wang noted. &#8220;But the ability of the vaccine candidate to raise substantial antibodies against the sugar shield in only two months is encouraging; other studies took up to four years to achieve similar results. This means that our molecule is a relatively strong inducer of the immune response.&#8221;</p>
<p>The researchers&#8217; next steps will be to conduct longer-term studies in combination with other vaccine candidates, hone in on what areas of gp120 the antibodies are binding to and determine how they can increase the antibodies&#8217; effectiveness at neutralizing HIV.</p>
<div class="clearfix"></div>
</div>
<p>The post <a rel="nofollow" href="https://irannewsdaily.com/2017/10/molecule-promise-hiv-vaccine/">New Molecule Shows Promise in HIV Vaccine Design</a> appeared first on <a rel="nofollow" href="https://irannewsdaily.com">Iran News Daily</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://irannewsdaily.com/2017/10/molecule-promise-hiv-vaccine/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
